Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Molecularly, skin disease shares much with development

Jan. 25, 2021

Target enrollment complete in diabetic foot ulcer study of SkinTE

Jan. 22, 2021

12-Week study shows benvitimod cream is efficacious and safe in plaque psoriasis

Jan. 21, 2021

Arcutis plans to study roflumilast foam in phase III for seborrheic dermatitis

Jan. 21, 2021

Positive confirmatory data from atopic dermatitis cohort of EDP-1815 phase Ib trial

Jan. 21, 2021

Arcutis initiates pivotal phase III studies of roflumilast cream in patients with atopic dermatitis

Jan. 14, 2021

Dovobet Foam approved in Japan for psoriasis

Jan. 13, 2021

Cara opens phase II trial of oral difelikefalin for notalgia paresthetica pruritus

Jan. 11, 2021

New phase II trial evaluates SCD-044 for moderate to severe plaque psoriasis

Jan. 5, 2021

New CTP synthase 1 inhibitors described by Step Pharma

Dec. 29, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...